Lime Chemicals

  • Market Cap: Micro Cap
  • Industry: Commodity Chemicals
  • ISIN: INE891G01011
  • NSEID:
  • BSEID: 507759
INR
13.75
0.2 (1.48%)
BSENSE

Dec 05

BSE+NSE Vol: 131

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

131 (6.16%) Volume

Shareholding (Sep 2025)

FII

2.35%

Held by 1 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

29.27%

What does Lime Chemicals do?

06-Jun-2025

Lime Chemicals Ltd manufactures Calcium Carbonate and operates in the Commodity Chemicals industry as a Micro Cap company. As of March 2025, it reported net sales of 2 Cr and a market cap of Rs 11 Cr.

Overview: <BR>Lime Chemicals Ltd is engaged in the manufacture of Calcium Carbonate and operates within the Commodity Chemicals industry, classified as a Micro Cap company.<BR><BR>History: <BR>Lime Chemicals Ltd was incorporated in 1970 in Maharashtra. The company went public in 1986, marking a significant milestone. The latest quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot: <BR>Net Sales: 2 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 0 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: Rs 11 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 11.00 <BR>Industry P/E: 47 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 2.76 <BR>Return on Equity: 12.50% <BR>Price to Book: 6.38 <BR><BR>Contact Details: <BR>Address: 404/405 Neco Chambers 4 Th Flo, Plot No 48 Sector 11 Navi Mumbai Maharashtra : 400614 <BR>Tel: 91-022-27561976/77 <BR>Email: info@limechem.com <BR>Website: http://www.limechem.com

Read More

Has Lime Chemicals declared dividend?

06-Jun-2025

Lime Chemicals Ltd has declared a 12% dividend, amounting to 0.9700 per share, with an ex-date of September 25, 2006. However, the dividend yield is 0%, and total returns over various periods have shown significant losses.

Lime Chemicals Ltd has declared a 12% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 12%<BR>- Amount per share: 0.9700<BR>- Ex-date: 25 Sep 06<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the 6-month period, the price return was -33.64%, the dividend return was 0%, resulting in a total return of -33.64%.<BR><BR>For the 1-year period, the price return was -32.63%, the dividend return was 0%, leading to a total return of -32.63%.<BR><BR>Over the 2-year period, the price return was -23.64%, the dividend return was 0%, which resulted in a total return of -23.64%.<BR><BR>In the 3-year period, the price return was -34.55%, with a dividend return of 0%, culminating in a total return of -34.55%.<BR><BR>During the 4-year period, the price return was -42.15%, the dividend return was 0%, resulting in a total return of -42.15%.<BR><BR>For the 5-year period, the price return was -23.47%, the dividend return was 0%, leading to a total return of -23.47%.<BR><BR>Overall, while Lime Chemicals Ltd has declared a dividend, the dividend yield is 0%, indicating no returns from dividends in recent periods. The total returns across various periods reflect significant losses, suggesting a challenging financial performance.

Read More

Who are the peers of the Lime Chemicals?

03-Jun-2025

Lime Chemicals' peers include Tata Chemicals, Chemplast Sanmar, GHCL, India Glycols, Fischer Medical, Tulasee Bio-Eth., Kobo Biotech, and Padmanabh Inds. Lime Chemicals has below-average management risk and a 1-year return of -37.18%, the lowest among its peers.

Peers: The peers of Lime Chemicals are Tata Chemicals, Chemplast Sanmar, GHCL, India Glycols, Fischer Medical, Tulasee Bio-Eth., Kobo Biotech, and Padmanabh Inds.<BR><BR>Quality Snapshot: Excellent management risk is observed at GHCL and Chemplast Sanmar, while Average management risk is found at Tata Chemicals and India Glycols. Below Average management risk is noted for Lime Chemicals and Fischer Medical. Growth is Below Average for Tata Chemicals, Chemplast Sanmar, GHCL, India Glycols, Lime Chemicals, and the rest. Capital Structure ratings show Excellent at GHCL, Good at Fischer Medical, Average at Tata Chemicals and the rest, and Below Average at Chemplast Sanmar, India Glycols, and Lime Chemicals.<BR><BR>Return Snapshot: India Glycols has the highest 1-year return at 150.46%, while Lime Chemicals has the lowest at -37.18%. Lime Chemicals' 1-year return is significantly lower than all its peers. Additionally, GHCL, Chemplast Sanmar, Lime Chemicals, Tulasee Bio-Eth., Kobo Biotech, and Fischer Medical have negative six-month returns.

Read More

Is Lime Chemicals overvalued or undervalued?

09-Jun-2025

As of April 25, 2023, Lime Chemicals is considered overvalued and classified as "risky," with a PE ratio of 11.25, a Price to Book Value of 6.39, and a year-to-date return of -26.83%, significantly underperforming compared to its peers like Solar Industries and Godrej Industries.

As of 25 April 2023, Lime Chemicals has moved from a grade of "does not qualify" to "risky." The company is currently considered overvalued. Key ratios include a PE ratio of 11.25, a Price to Book Value of 6.39, and a PEG ratio of 0.08, which indicates a significant disparity in valuation metrics compared to its peers. <BR><BR>In comparison to its peers, Lime Chemicals' PE ratio is notably lower than Solar Industries, which has a PE of 123.77, and Godrej Industries, which stands at 46.63. The EV to EBITDA ratio of Lime Chemicals is -16.10, contrasting sharply with Godrej Industries' 34.36, highlighting its poor profitability relative to industry standards. Additionally, the company's recent stock performance has been underwhelming, with a year-to-date return of -26.83% compared to a 5.62% gain in the Sensex, reinforcing the notion of its overvaluation amidst a challenging market environment.

Read More

What is the technical trend for Lime Chemicals?

09-Jun-2025

As of May 14, 2025, Lime Chemicals is in a mildly bearish trend, with daily moving averages and weekly Dow Theory indicating bearish sentiment, while mixed signals from MACD, Bollinger Bands, and KST suggest potential for stabilization.

As of 14 May 2025, the technical trend for Lime Chemicals has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by the daily moving averages indicating a bearish sentiment and the weekly Dow Theory also reflecting a mildly bearish outlook. The MACD shows a mildly bullish signal on the weekly chart but remains bearish on the monthly, which adds to the mixed signals. The Bollinger Bands and KST both indicate bearish conditions on the monthly, while the RSI shows no significant signals in either time frame. Overall, the strength of the bearish trend is moderate, with some conflicting indicators suggesting potential for stabilization.

Read More

Who are in the management team of Lime Chemicals?

16-Jul-2025

As of March 2022, the management team of Lime Chemicals includes A H Dawoodani (Managing Director), Avinash Mukesh Jhaveri (Chairman & Independent Director), and several other directors and officers.

As of March 2022, the management team of Lime Chemicals includes the following individuals:<BR><BR>1. A H Dawoodani - Managing Director<BR>2. Shahnaz A Dawoodani - Director<BR>3. Akbar Virani - Director<BR>4. Husen Somji - Independent Director<BR>5. Avinash Mukesh Jhaveri - Chairman & Independent Director<BR>6. S. Neha T. Botadra - Company Secretary & Compliance Officer<BR><BR>The team is led by A H Dawoodani as the Managing Director, with Avinash Mukesh Jhaveri serving as the Chairman and Independent Director.

Read More

Who are the top shareholders of the Lime Chemicals?

17-Jul-2025

The top shareholders of Lime Chemicals include Rahim Ahmed Dawoodani with 10.62%, Devanshi Parimal Merchant with 12.3%, and individual investors holding 64.14%. There is also a foreign institutional investor with 2.35% and five mutual fund schemes with a combined 0.05%, with no pledged promoter holdings.

The top shareholders of Lime Chemicals include both individual and institutional investors. The promoter with the highest holding is Rahim Ahmed Dawoodani, who owns 10.62% of the company. The highest public shareholder is Devanshi Parimal Merchant, holding 12.3%. Additionally, individual investors collectively hold a significant portion of 64.14%. There is also some institutional presence, with one foreign institutional investor (FII) holding 2.35% and five mutual fund schemes holding a combined 0.05%. Notably, there are no pledged promoter holdings.

Read More

How big is Lime Chemicals?

24-Jul-2025

As of 24th July, Lime Chemicals Ltd has a market capitalization of 12.00 Cr, with recent net sales of 9.66 Cr and a net profit of 0.22 Cr over the last four quarters.

As of 24th July, <BR><BR>Market Cap: Lime Chemicals Ltd has a market capitalization of 12.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 9.66 Cr, while the sum of Net Profit for the same period is 0.22 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the latest annual data is March 2024. Shareholder's Funds stand at 1.74 Cr, and Total Assets are valued at 10.67 Cr.

Read More

When is the next results date for Lime Chemicals?

07-Nov-2025

The next results date for Lime Chemicals is 14 November 2025.

The next results date for Lime Chemicals is scheduled for 14 November 2025.

Read More

How has been the historical performance of Lime Chemicals?

17-Nov-2025

Lime Chemicals has experienced a significant decline in net sales and profitability from INR 43.44 crore in March 2019 to INR 9.67 crore in March 2025, with negative operating profit margins and decreasing profit before and after tax. The company faces ongoing financial challenges, reflected in negative cash flow and reduced total assets and liabilities.

Answer:<BR>The historical performance of Lime Chemicals shows a declining trend in net sales and profitability over the years, with significant fluctuations in various financial metrics.<BR><BR>Breakdown:<BR>Lime Chemicals has experienced a steady decline in net sales from INR 43.44 crore in March 2019 to INR 9.67 crore in March 2025. The total operating income followed a similar trend, decreasing from INR 43.44 crore in March 2019 to INR 9.67 crore in March 2025. The raw material costs and purchase of finished goods have also varied, with raw material costs rising to INR 3.19 crore in March 2025 from INR 0.44 crore in March 2023. The company reported an operating profit margin that turned negative in recent years, reaching -1.34% in March 2025, compared to a positive margin of 7.87% in March 2019. Profit before tax showed a decline, with a profit of INR 0.24 crore in March 2025, down from INR 3.08 crore in March 2023. The profit after tax also reflected this downward trend, with INR 0.22 crore in March 2025 compared to INR 2.76 crore in March 2023. The company's total liabilities decreased from INR 24.07 crore in March 2020 to INR 10.10 crore in March 2025, while total assets also fell from INR 24.07 crore to INR 10.10 crore in the same period. Cash flow from operating activities has been negative in recent years, indicating ongoing financial challenges. Overall, Lime Chemicals has faced significant operational and financial difficulties, leading to a decline in key performance metrics over the years.

Read More

Should I buy, sell or hold Lime Chemicals?

17-Nov-2025

Are Lime Chemicals latest results good or bad?

18-Nov-2025

Lime Chemicals' latest results are concerning, with a 38.66% year-on-year revenue decline and a net loss of ₹0.16 crores, marking the third consecutive quarter of revenue contraction. The company's stock has also significantly underperformed, raising serious concerns about its long-term viability.

Lime Chemicals' latest results are quite concerning. The company reported a significant revenue decline of 38.66% year-on-year, with net sales dropping to ₹1.46 crores in Q2 FY26. This marks the third consecutive quarter of revenue contraction, indicating ongoing struggles in maintaining operational viability.<BR><BR>Additionally, Lime Chemicals posted a net loss of ₹0.16 crores, a stark contrast to the profit recorded in the previous quarter. The operating margin remains deeply negative at -10.96%, highlighting persistent operational losses over several quarters.<BR><BR>The stock has also underperformed significantly, trading 52.20% below its 52-week high and experiencing a 50.07% decline over the past year, while the broader market has seen gains.<BR><BR>Overall, these results reflect a downward spiral for the company, raising serious concerns about its long-term viability and financial health.

Read More

Why is Lime Chemicals falling/rising?

04-Dec-2025

As of 04-Dec, Lime Chemicals Ltd's stock price is at 13.75, reflecting a 0.51% decrease and a significant year-to-date decline of 42.71%. The stock is trading below its moving averages, indicating a bearish trend despite a recent increase in delivery volume.

As of 04-Dec, Lime Chemicals Ltd's stock price is falling, currently at 13.75, which reflects a decrease of 0.07 or 0.51%. The stock has underperformed its sector by 0.3% today and has been on a consecutive decline for the last two days, resulting in a total drop of 1.72% over that period. <BR><BR>In terms of longer-term performance, the stock has shown significant declines, with a year-to-date decrease of 42.71% and a one-year decline of 47.50%. Additionally, the stock is trading below its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend.<BR><BR>Despite a notable increase in delivery volume, which rose by 247.47% against the 5-day average, the overall performance metrics suggest that investor sentiment remains negative, contributing to the stock's decline.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

  • Poor long term growth as Net Sales has grown by an annual rate of -21.92% and Operating profit at -45.07% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at 3.92 times
2

Flat results in Sep 25

3

Risky - Negative EBITDA

4

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Commodity Chemicals

stock-summary
Market cap

INR 9 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

40

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

2.67

stock-summary
Return on Equity

-0.56%

stock-summary
Price to Book

4.97

Revenue and Profits:
Net Sales:
1 Cr
(Quarterly Results - Sep 2025)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-14.06%
0%
-14.06%
6 Months
-20.29%
0%
-20.29%
1 Year
-45.46%
0%
-45.46%
2 Years
-44.22%
0%
-44.22%
3 Years
-47.62%
0%
-47.62%
4 Years
-48.79%
0%
-48.79%
5 Years
-21.2%
0%
-21.2%

Latest dividend: 0.9700 per share ex-dividend date: Sep-25-2006

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News
Announcements stock-summary

Board Meeting Outcome for Outcome Of Board Meeting Held On 14Th November 2025

14-Nov-2025 | Source : BSE

Outcome of the Board Meeting held on 14th November is attached herewith.

Un-Audited Financial Results For The Quarter Ended On 30Th September 2025

14-Nov-2025 | Source : BSE

The un-audited financial results for the quarter ended on 30th September 2025 approved on 14th November 2025 is attached herewith.

Board Meeting Intimation for Board Meeting On 14Th November 2025

06-Nov-2025 | Source : BSE

Lime Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve A meeting of Board of Directors will be held on Friday the 14th November 2025 to consider and approve un-audited financial results for the quarter and half year ended on 30th September 2025.

Corporate Actions stock-summary
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Lime Chemicals Ltd has declared 12% dividend, ex-date: 25 Sep 06

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-21.92%
EBIT Growth (5y)
-45.07%
EBIT to Interest (avg)
-1.05
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
2.67
Sales to Capital Employed (avg)
3.31
Tax Ratio
20.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
2.40%
ROCE (avg)
-27.85%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
40
Price to Book Value
4.97
EV to EBIT
-13.75
EV to EBITDA
-13.75
EV to Capital Employed
2.08
EV to Sales
1.82
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-9.23%
ROE (Latest)
-0.56%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 5 Schemes (0.05%)

FIIs

Held by 1 FIIs (2.35%)

Promoter with highest holding

Rahim Ahmed Dawoodani (10.62%)

Highest Public shareholder

Devanshi Parimal Merchant (12.3%)

Individual Investors Holdings

63.96%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is -38.66% vs 5.78% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is -220.00% vs 54.55% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1.46",
          "val2": "2.38",
          "chgp": "-38.66%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.16",
          "val2": "-0.07",
          "chgp": "-128.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.16",
          "val2": "-0.05",
          "chgp": "-220.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-10.96%",
          "val2": "-2.94%",
          "chgp": "-8.02%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is -38.93% vs -1.45% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -230.00% vs 131.25% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3.31",
          "val2": "5.42",
          "chgp": "-38.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.33",
          "val2": "0.06",
          "chgp": "-650.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.01",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.13",
          "val2": "0.10",
          "chgp": "-230.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-9.97%",
          "val2": "1.11%",
          "chgp": "-11.08%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -0.87% vs -33.09% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 142.11% vs -113.10% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "8.02",
          "val2": "8.09",
          "chgp": "-0.87%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.10",
          "val2": "-0.66",
          "chgp": "115.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.01",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.16",
          "val2": "-0.38",
          "chgp": "142.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "1.25%",
          "val2": "-8.16%",
          "chgp": "9.41%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is -7.46% vs -32.49% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 144.90% vs -117.75% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9.67",
          "val2": "10.45",
          "chgp": "-7.46%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.13",
          "val2": "-0.77",
          "chgp": "83.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.15",
          "val2": "0.03",
          "chgp": "400.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.22",
          "val2": "-0.49",
          "chgp": "144.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1.34%",
          "val2": "-7.37%",
          "chgp": "6.03%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Sep'25 - YoYstock-summary
Sep'25
Sep'24
Change(%)
Net Sales
1.46
2.38
-38.66%
Operating Profit (PBDIT) excl Other Income
-0.16
-0.07
-128.57%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.16
-0.05
-220.00%
Operating Profit Margin (Excl OI)
-10.96%
-2.94%
-8.02%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in quarter ended Sep 2025 is -38.66% vs 5.78% in Sep 2024

Direction Arrows
Standalone Net Profit

YoY Growth in quarter ended Sep 2025 is -220.00% vs 54.55% in Sep 2024

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary
Sep'25
Sep'24
Change(%)
Net Sales
3.31
5.42
-38.93%
Operating Profit (PBDIT) excl Other Income
-0.33
0.06
-650.00%
Interest
0.01
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.13
0.10
-230.00%
Operating Profit Margin (Excl OI)
-9.97%
1.11%
-11.08%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is -38.93% vs -1.45% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is -230.00% vs 131.25% in Sep 2024

Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
8.02
8.09
-0.87%
Operating Profit (PBDIT) excl Other Income
0.10
-0.66
115.15%
Interest
0.00
0.01
-100.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.16
-0.38
142.11%
Operating Profit Margin (Excl OI)
1.25%
-8.16%
9.41%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -0.87% vs -33.09% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 142.11% vs -113.10% in Dec 2023

Annual Results Snapshot (Standalone) - Mar'25stock-summary
Mar'25
Mar'24
Change(%)
Net Sales
9.67
10.45
-7.46%
Operating Profit (PBDIT) excl Other Income
-0.13
-0.77
83.12%
Interest
0.15
0.03
400.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.22
-0.49
144.90%
Operating Profit Margin (Excl OI)
-1.34%
-7.37%
6.03%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is -7.46% vs -32.49% in Mar 2024

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2025 is 144.90% vs -117.75% in Mar 2024

stock-summaryCompany CV
About Lime Chemicals Ltd stock-summary
stock-summary
Lime Chemicals Ltd
Micro Cap
Commodity Chemicals
Lime Chemicals Ltd (LCL) was incorporated in 1970 in Maharashtra. The Company is engaged in manufacture of Calcium Carbonate including Tooth Paste, Pharmaceuticals, PVC products, Rubber, Plastic, Polymer, Cable, Leather, Paper and Paints. Upgradation of technology & continuous product development gave the Company strength to consolidate its position in the Indian market, and the first major milestone we achieved was in year 1986 when the Company went Public.
Company Coordinates stock-summary
Company Details
404/405 Neco Chambers 4 Th Flo, Plot No 48 Sector 11 Navi Mumbai Maharashtra : 400614
stock-summary
Tel: 91-022-27561976/77
stock-summary
info@limechem.com
Registrar Details
Bigshare Services Pvt Ltd , E-2 , Ansa Industrial Estate, Saki Vihar Road, Saki Naka, Andheri (E), Mumbai